日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in Adults: A Systematic Review and Meta-Analysis

胰高血糖素样肽-1受体激动剂治疗成人减肥效果的异质性:系统评价和荟萃分析

Alexander, G Caleb; Xiao, Xuya; Dilek, Sophie; Lewis, Sydney; Deng, Qilin; Kim, Minji; Bolanle, Dami; Saldanha, Ian J; Mehta, Hemalkumar B

Incident diabetes after switching to integrase strand transfer inhibitors in people with HIV in the USA and Canada: a cohort study

美国和加拿大 HIV 感染者改用整合酶链转移抑制剂后新发糖尿病:一项队列研究

Hwang, Y Joseph; Lesko, Catherine R; Brown, Todd T; Alexander, G Caleb; Althoff, Keri N; Zalla, Lauren C; Pytell, Jarratt D; Falade-Nwulia, Oluwaseun; Tseng, Eva; Moore, Richard D; Marconi, Vincent C; Koethe, John R; Silverberg, Michael J; Horberg, Michael A; Lang, Raynell; Sterling, Timothy R; Fojo, Anthony Todd

Is artificial intelligence a friend or foe to epidemiology?

人工智能对流行病学来说是朋友还是敌人?

Rashidi, Emaan; Brooks, Madeline; Hassoon, Ahmed; Mehta, Shruti; Althoff, Keri; Alexander, G Caleb

Use of Glucagon-Like Peptide-1 Agonists Among Individuals Undergoing Bariatric Surgery in the US

美国接受减肥手术的患者中使用胰高血糖素样肽-1激动剂的情况

Kim, Minji; Schweitzer, Michael A; Kim, Ji Soo; Alexander, G Caleb; Mehta, Hemalkumar B

Screening, brief intervention, and referral to treatment training for Nigerian primary care physicians: A pilot evaluation of knowledge, attitudes, self-efficacy, and barriers to implementation

针对尼日利亚基层医生开展筛查、简短干预和转诊治疗培训:一项关于知识、态度、自我效能和实施障碍的试点评估

Anaba, Honest; Thrul, Johannes; Oborevwori, Elohor; Oluwayomi, Osiyemi; Alexander, G Caleb

Interventions to improve patient safety during the COVID-19 pandemic: a systematic review

新冠肺炎疫情期间改善患者安全的干预措施:系统评价

Wu, Albert W; Trigg, Katelyn; Zhang, Allen; Alexander, G Caleb; Haut, Elliott R; Rock, Clare; McDonald, Kathryn; Padula, William; Fisseha, Sarah; Duncan, Rosemary; Black, Joyce; Newman-Toker, David E; Papieva, Irina; Dhingra-Kumar, Neelam; Wilson, Renee F

Research and development investments for biologics independently developed by US biotechnology startups, 2017-2023

2017-2023年美国生物技术初创公司独立研发的生物制剂的研发投资

Odouard, Ilina C; Kang, So-Yeon; Mo, Jessica; Anderson, Gerard F; Alexander, G Caleb

Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality

娱乐和医用大麻合法化与阿片类药物处方和死亡率

Nguyen, Hai V; McGinty, Emma E; Mital, Shweta; Alexander, G Caleb

Use of Oral and Emergency Contraceptives After the US Supreme Court's Dobbs Decision

美国最高法院多布斯案判决后口服避孕药和紧急避孕药的使用情况

Qato, Dima M; Myerson, Rebecca; Shooshtari, Andrew; Guadamuz, Jenny S; Alexander, G Caleb

Deprescribing of antidepressants: development of indicators of high-risk and overprescribing using the RAND/UCLA Appropriateness Method

减少抗抑郁药处方:利用 RAND/UCLA 适宜性方法开发高风险和过度处方指标

Brisnik, Vita; Vukas, Jochen; Jung-Sievers, Caroline; Lukaschek, Karoline; Alexander, G Caleb; Thiem, Ulrich; Thürmann, Petra; Schüle, Cornelius; Fischer, Sebastian; Baum, Erika; Drey, Michael; Harder, Sebastian; Niebling, Wilhelm; Janka, Ulrike; Krause, Olaf; Gensichen, Jochen; Dreischulte, Tobias